GO:0006766 vitamin metabolic process: Genes & Research

Vitamin metabolic process (GO:0006766) encompasses the chemical reactions and pathways involving vitamins, a group of unrelated organic substances required in trace amounts for normal metabolic functioning. Vitamins are essential nutrients that cannot be synthesized in sufficient quantities by humans and must be obtained from the diet; they function primarily as coenzymes or precursors to coenzymes in diverse metabolic reactions. The term includes both water-soluble vitamins (such as B-complex vitamins and vitamin C) and fat-soluble vitamins (A, D, E, and K), each with distinct metabolic fates and regulatory roles. Research into vitamin metabolic process is critical because perturbations in these pathways contribute to a wide range of human diseases, including cancer, neurological disorders, and metabolic syndromes. For example, B vitamins are integral to immune regulation and cancer biology, and their metabolism influences epigenetic marks. Fat-soluble vitamin metabolic processes have been linked to glioma progression, suggesting that these pathways may be therapeutically relevant. Moreover, vitamin neurotoxicity and malabsorption syndromes underscore the importance of tight regulation of vitamin levels. Understanding the genes and mechanisms underlying vitamin metabolic process provides a foundation for developing targeted interventions, including nutritional therapies and CRISPR-based models to study gene function. This article synthesizes authoritative QuickGO data and verified PubMed literature to deliver a research-grade overview of GO:0006766, optimized for both human readers and AI-driven retrieval.

GO:0006766, vitamin metabolic process, is defined as the chemical reactions and pathways involving vitamins. Vitamins are a general term for a number of unrelated organic substances that occur in many foods in small amounts and are necessary in trace amounts for the normal metabolic functioning of the body. Vitamins may be water-soluble or fat-soluble and usually serve as components of coenzyme systems.

Vitamin metabolic process is fundamental to human health because vitamins are essential micronutrients that cannot be synthesized endogenously in sufficient amounts and must be obtained from the diet. These pathways ensure the proper utilization of vitamins as coenzymes in energy metabolism, DNA synthesis, antioxidant defense, and epigenetic regulation. Dysregulation of vitamin metabolism is implicated in numerous pathologies, including cancer, neurodegenerative diseases, and kidney stone formation. Therefore, understanding the genes and mechanisms of vitamin metabolic process is crucial for developing preventive and therapeutic strategies.

The following genes encode enzymes, transporters, and regulatory proteins that participate in vitamin metabolic process, as supported by published literature.

Vitamin metabolic process is regulated at multiple levels, including transcriptional control of metabolic enzymes, feedback inhibition by end products, and hormonal signals. For example, vitamin D metabolism is tightly regulated by parathyroid hormone, fibroblast growth factor 23, and calcium levels. One-carbon metabolism involving B vitamins is regulated by the availability of substrates and allosteric inhibition of key enzymes like MTHFR. Additionally, epigenetic mechanisms, including DNA methylation and histone modifications, can influence the expression of vitamin-metabolizing genes, creating a feedback loop between vitamin status and gene regulation.

Dysregulation of vitamin metabolic process is increasingly recognized in cancer. B vitamins, particularly folate and vitamin B12, are essential for nucleotide synthesis and methylation, and their imbalance can promote oncogenesis. Fat-soluble vitamin metabolic processes, such as those involving vitamin A and D, have been associated with glioma progression, where altered expression of metabolic enzymes correlates with patient outcomes. Vitamin D receptor polymorphisms and altered vitamin D metabolism are linked to various cancers, including colorectal and breast cancer. Furthermore, vitamins as epidrugs can influence tumor suppressor gene expression and cancer stem cell behavior.

The nervous system is particularly sensitive to vitamin imbalances. Vitamin neurotoxicity, such as from excessive vitamin A or B6, can cause neuropathy and ataxia. Conversely, deficiencies in B vitamins, especially B12 and folate, lead to neurological symptoms including cognitive decline and peripheral neuropathy. Malabsorption syndromes, such as pernicious anemia, disrupt vitamin B12 uptake and metabolism, resulting in subacute combined degeneration of the spinal cord. These examples highlight the critical role of vitamin metabolic process in neuronal health.

Vitamin D metabolic process is intimately linked to calcium homeostasis, and its dysregulation can lead to kidney stone formation. Mutations in CYP24A1, which inactivates vitamin D, cause hypercalcemia and nephrolithiasis. Additionally, excessive vitamin D supplementation or increased endogenous synthesis can elevate urinary calcium, promoting stone formation. Understanding the genes involved in vitamin D metabolism is therefore important for managing kidney stone disease.

RNA-seq and microarray analyses can profile the expression of genes involved in vitamin metabolic process under different conditions, such as vitamin deprivation or supplementation. These methods help identify transcriptional changes in metabolic enzymes and transporters. Additionally, genome-wide association studies (GWAS) have linked polymorphisms in vitamin-metabolizing genes to disease risk.

Mass spectrometry-based metabolomics allows quantification of vitamin metabolites in cells and tissues, providing direct readouts of pathway activity. Enzymatic assays can measure the activity of specific vitamin-metabolizing enzymes, such as MTHFR or CYP24A1. These biochemical approaches are essential for validating findings from genetic studies.

CRISPR knockout library screening enables unbiased identification of genes required for vitamin metabolism and uptake. For example, screens for resistance to vitamin deprivation or toxicity can reveal novel transporters and enzymes. Coupled with bioinformatics, these screens prioritize candidate genes for further study.

Fluorescent reporters and biosensors can monitor vitamin levels or pathway activity in live cells. For instance, genetically encoded sensors for vitamin C or retinoic acid allow real-time tracking of metabolic flux. Imaging of tagged proteins (e.g., VDR-GFP) reveals subcellular localization and dynamics.

Researchers studying vitamin metabolic process-related genes often need to determine whether a candidate gene is causally involved in vitamin homeostasis, disease progression, or treatment response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.

Vitamin metabolic process (GO:0006766) is a fundamental biological process that encompasses the absorption, conversion, and utilization of vitamins as essential coenzymes and signaling molecules. Its dysregulation is implicated in cancer, neurological disorders, kidney stones, and immune dysfunction, making it a critical area of biomedical research. Advances in CRISPR-based models and multi-omics technologies are accelerating the discovery of genes and mechanisms underlying vitamin metabolism, offering new opportunities for therapeutic intervention and personalized nutrition. EDITGENE provides comprehensive CRISPR services, including knockout, point mutation, knock-in, overexpression, and library screening, to support researchers in dissecting vitamin metabolic pathways and translating findings into clinical applications.